Plain-English translation of NCT07678866 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is a preliminary study testing a pulsed electric field ablation system as a new treatment for adults with type 2 diabetes whose blood sugar levels have not improved enough with medications alone. The treatment uses electrical pulses to help control blood sugar. Researchers will measure how well this treatment works and how safe it is over a 6-month to 12-month period.
Many people with type 2 diabetes take two or three medications but still struggle to keep their blood sugar at healthy levels. This trial exists to explore whether this new electrical treatment could help people whose diabetes is not well controlled by drugs alone.
You likely qualify if…
You likely don't qualify if…
You would receive the pulsed electric field ablation treatment as an outpatient procedure. Your blood sugar control, weight, and overall health would be monitored at follow-up visits at 1 month, 3 months, 6 months, and 12 months after treatment. You would need to keep taking your current diabetes medications at the same dose throughout the study, and you'll have blood tests to measure how well your blood sugar is being controlled over time.
AI-generated summary from trial data · Jul 4, 2026 · Not medical advice
China